|
|
|
|
||
Re: Prospectus 5/29/2020 Are they really of intense interest right now? All the hype leading to the approvals and respective company buyouts ended a year or two back. Patient numbers are in the hundreds not thousands. This is a good summation as to why:- The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden https://ascopubs.org/doi/full/10.1200/EDBK_238691 |
return to message board, top of board |